How Boston Scientific's Surprise Setback Bolstered Edwards, Medtronic, AbbottInvestors Business Daily • 05/28/25
Edwards' New Late-Breaking Data on Severe AS Expected to Boost StockZacks Investment Research • 05/23/25
Prompt Intervention for Severe Aortic Stenosis Patients Demonstrates Lower Healthcare Costs, Improved Clinical OutcomesBusiness Wire • 05/22/25
Edwards Lifesciences to Present at the BofA Securities 2025 Health Care ConferenceBusiness Wire • 05/06/25
Edwards TAVR Receives FDA Approval for Patients With Asymptomatic Severe Aortic StenosisBusiness Wire • 05/01/25
EW Q1 Earnings & Revenues Beat, Stock Climbs, '25 Sales View RaisedZacks Investment Research • 04/24/25
Edwards Lifesciences (EW) Q1 Earnings: How Key Metrics Compare to Wall Street EstimatesZacks Investment Research • 04/23/25
Unlocking Q1 Potential of Edwards Lifesciences (EW): Exploring Wall Street Estimates for Key MetricsZacks Investment Research • 04/18/25
Edwards SAPIEN M3 Receives CE Mark, Becoming World's First Transfemoral Transcatheter Mitral Valve Replacement SystemBusiness Wire • 04/14/25
New Data Confirm Rapid, Unpredictable Progression of Severe Aortic Stenosis and Need for Urgent Referral and Evaluation of PatientsBusiness Wire • 03/31/25
Scaling its Investment Platform in Minimally Invasive Care, Intuitive Ventures Appoints Terri Burke as Senior Partner and Ross Jaffe as Venture AdvisorBusiness Wire • 03/06/25
Edwards Lifesciences to Present at the TD Cowen 45th Annual Health Care ConferenceBusiness Wire • 02/25/25
Heart Devices-Focused Edwards Lifesciences Confident in 2025 Outlook, Analyst Sees Long-Term StrengthBenzinga • 02/12/25